Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nasrin Refaian, Ph.D.

Concepts (65)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Nasrin Refaian's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Nasrin Refaian has written about over time.
Lymphangiogenesis, 1 publications between 2014 and 2014, average publication date August 2014. Gene Expression Regulation, Neoplastic, 2 publications between 2014 and 2015, average publication date December 2014. Vascular Endothelial Growth Factor A, 2 publications between 2014 and 2015, average publication date December 2014. Lymphatic Vessels, 3 publications between 2014 and 2016, average publication date June 2015. Conjunctival Neoplasms, 1 publications between 2015 and 2015, average publication date July 2015. RNA, Messenger, 1 publications between 2015 and 2015, average publication date July 2015. Vascular Endothelial Growth Factor C, 1 publications between 2015 and 2015, average publication date July 2015. Limbus Corneae, 2 publications between 2015 and 2016, average publication date December 2015. Melanoma, 3 publications between 2014 and 2022, average publication date June 2017. Uveal Neoplasms, 3 publications between 2014 and 2022, average publication date June 2017. Cell Adhesion Molecules, 1 publications between 2021 and 2021, average publication date December 2021. Microfilament Proteins, 1 publications between 2021 and 2021, average publication date December 2021. Phosphoproteins, 1 publications between 2021 and 2021, average publication date December 2021. Receptors, Interleukin-6, 1 publications between 2021 and 2021, average publication date December 2021. Th17 Cells, 1 publications between 2021 and 2021, average publication date December 2021. Ribosomal Protein S6, 1 publications between 2022 and 2022, average publication date August 2022. TOR Serine-Threonine Kinases, 1 publications between 2022 and 2022, average publication date August 2022. Glaucoma, 1 publications between 2023 and 2023, average publication date December 2023. Neurodegenerative Diseases, 1 publications between 2023 and 2023, average publication date December 2023.

To see the data from this visualization as text, click here.
Refaian's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.